Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)

Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)

Introduction Although there are studies about sepsis treatment in different age groups, data on immunoglobulin-M (IgM)-enriched intravenous immunoglobulin use in pediatric intensive care units (PICUs) are limited. The aim of this study was to evaluate the clinical features and prognoses of children...

Full description

Bibliographic Details
Main Authors: Emin Abdullayev, Omer Kilic, Gurkan Bozan, Eylem Kiral, Merve Iseri Nepesov, Ener Cagri Dinleyici
Format: Article
Language:English
Published: Taylor & Francis Group 2020-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
igm-enriched intravenous immunoglobulin
sepsis
septic shock
children
Online Access:http://dx.doi.org/10.1080/21645515.2019.1711298

Internet

http://dx.doi.org/10.1080/21645515.2019.1711298

Similar Items